I know quite a bit about this drug, and its potential, which is incredible. The biggest problem they have is that some in the studies want to stay on it, and can't until it is approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.